Estrogens decrease joint pain, but do not reduce joint swelling, in post-menopausal women

Menopause. 2013 Jun;20(6):600-608

Use of growth hormone therapy for osteoporosis in postmenopausal women: 10 year follow-up

J Clin Endocrinol Metab. 2015 Sep;100(9):3251-9

Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls

Expert Opin Drug Saf. 2018 Apr;17(4):413-428

Eicosapentaenoic and docosahexaenoic acid supplementation in breast cancer patients

Nutr Cancer. 2014;66(1):68-76. doi: 10.1080/01635581.2014.847964. Epub 2013 Nov 25

Zoledronic acid given upfront maintains BMD in postmenopausal breast cancer patients

Cancer. 2012 Mar 1;118(5):1192-201. doi: 10.1002/cncr.26313. Epub 2011 Oct 10

WCO-IOF 2016: Lasofoxifene, raloxifene, and placebo for BMD in postmenopausal women

Evaluating raloxifene in postmenopausal Japanese women with osteoporosis or osteopenia

Clin Interv Aging. 2014 Nov 5;9:1879-1893.

The effect of adjuvant aromatase inhibitors on BMD in women with breast cancer

Lancet Oncol. 2014 Apr;15(4):474-82. doi: 10.1016/S1470-2045(14)70035-X. Epub 2014 Mar 11

Olive leaf extract improves osteocalcin level & serum lipid profile in osteopenic women

J Nutr Health Aging. 2015;19(1):77-86

Denosumab reduces secondary fragility fracture risk in osteoporotic women

Climacteric. 2015 Jun 1:1-23

Short-term benefits of tamoxifen in Dupuytren patients with a predisposition to fibrosis

J Bone Joint Surg Am. 2014 Apr 16;96(8):655-62